Suppr超能文献

年龄和性别对缺血性中风的影响:单中心神经重症监护病房经验

The Effect of Age and Sex on Ischemıc Stroke: A Sıngle-Centred Neuro-Intensıve Care Unıt Experıence.

作者信息

Guzeldag Seda

机构信息

Department of Neuro-Intensive Care Unit, Kayseri City Hospital, Turkey.

出版信息

Acta Neurol Taiwan. 2022 Dec 30;31(4):145-153.

Abstract

BACKGROUND

Age and sex are important determinants in the acute ischemic stroke (AIS). In this study, we examine the effects of age and sex on stroke survival and treatment in our clinic.

METHODS

We reviewed 368 AIS patients' records between January 1, 2019, and January 1, 2020, and formed three groups of age; Group 1:18-64 years, Group 2:65-79 years, and Group 3:more than 80 years. Then, we analyzed patients' data (sex, risk factors, hospital outcome, etc.), reperfusion therapy (RT) types (tissue plasminogen activator(tPA), endovascular therapy(EVT) and tPA+EVT), and reasons for none- RT (time mismatch, absolute and relative contraindications).

RESULTS

The majority of patients were age less than 65 years (48.6%), and the proportion of women increased in the older (56.1%). The most common stroke risk factor was hypertension (44.7%), but for those less than 65 years, it was obesity (46.6%). The most common RT type was tPA (56.7%), and no patients more than 80 years received tPA+EVT. The most common none-RT reason was time mismatch (65%). Being more than 80 years and female over 80 years (p=0.001, and p=0.005) were associated with increased mortality risk. While the frequency of none-RT patients was 28.8% in general, it increased up to 62.8% for the ones age more than 80 years. Also, the mortality rate was the highest in the none-RT(p less than 0.01).

CONCLUSIONS

RT practices differed according to patients' age and sex. The main determinant of the mortality rate was the lack of RT. However, the older patients and older women had less opportunity for RT.

摘要

背景

年龄和性别是急性缺血性卒中(AIS)的重要决定因素。在本研究中,我们探讨了年龄和性别对我院卒中患者生存及治疗的影响。

方法

我们回顾了2019年1月1日至2020年1月1日期间368例AIS患者的记录,并将其分为三个年龄组;第1组:18 - 64岁,第2组:65 - 79岁,第3组:80岁以上。然后,我们分析了患者的数据(性别、危险因素、医院结局等)、再灌注治疗(RT)类型(组织型纤溶酶原激活剂(tPA)、血管内治疗(EVT)和tPA + EVT)以及未进行RT的原因(时间不匹配、绝对和相对禁忌症)。

结果

大多数患者年龄小于65岁(48.6%),老年患者中女性比例增加(56.1%)。最常见的卒中危险因素是高血压(44.7%),但对于年龄小于65岁的患者,最常见的危险因素是肥胖(46.6%)。最常见的RT类型是tPA(56.7%),80岁以上患者无人接受tPA + EVT治疗。最常见的未进行RT的原因是时间不匹配(65%)。80岁以上以及80岁以上女性(p = 0.001和p = 0.005)与死亡风险增加相关。虽然未进行RT的患者总体频率为28.8%,但80岁以上患者中这一比例高达62.8%。此外,未进行RT患者的死亡率最高(p < 0.01)。

结论

RT治疗方法因患者年龄和性别而异。死亡率的主要决定因素是缺乏RT治疗。然而,老年患者和老年女性接受RT治疗的机会较少。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验